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Abstract: Retroviruses integrate a reverse transcribed double stranded DNA copy of their 
viral genome into the chromosomal DNA of cells they infect. Occasionally, exogenous 
retroviruses infect germ cells and when this happens a profound shift in the virus host 
dynamic occurs. Retroviruses maintained as hereditable viral genetic material are referred 
to as endogenous retroviruses (ERVs). After millions of years of co-evolution with their 
hosts many human ERVs retain some degree of function and a few have even become 
symbionts. Thousands of copies of endogenous retrovirus long terminal repeats (LTRs) 
exist in the human genome. There are approximately 3000 to 4000 copies of the ERV-9 
LTRs in the human genome and like other solo LTRs, ERV-9 LTRs can exhibit distinct 
promoter/enhancer activity in different cell lineages. It has been recently reported that a 
novel transcript of p63, a primordial member of the p53 family, is under the transcriptional 
control of an ERV-9 LTR [1]. The expression of different p63 transcript isoforms has been 
previously shown to have an important role in replenishing cutaneous epithelial stem cells 
and maintaining the fidelity of the female germ line [2]. In this recent report, a novel p63 
transcript, designated GTAp63, is described as specifically expressed in healthy human 
testes  and  germ  cell precursors of human testes  but  not  in  testicular cancer cells.  The 
ability of ERV-9 regulatory regions to contribute to the maintenance of male germ line 
stability is yet another example of how ERVs have evolved to serve an important function 
in the physiology of their human hosts. 
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The  complete  sequencing  of  the  human  genome  produced  an  unexpected  windfall—the  
discovery  that  genetic  elements  associated  with  endogenous  retroviruses  (ERVs)  far  outnumbered  
protein-encoding  genes.  The  transcriptional  and  transpositional  activities  of  ERVs  would  predict 
destabilization of a metazoan genome with such a high retroviral burden. Therefore, it is not surprising 
that in the millions of years since ERVs first established residence in the human genome most have 
been  rendered  inactive,  through  epigenetic  suppression,  recombination  or  mutation.  Replication-
competent retroviruses integrated into the host genome are flanked by long terminal repeats (LTRs). 
LTRs contain regulatory elements essential for gene expression including promoters, enhancers and 
polyadenylation sequences as well as sequences necessary for retrotransposition. Among human ERVs 
(HERVs) that retain some degree of function, several have acquired physiologically relevant roles in 
their  hosts.  For  example,  one  of  several  integrants  of  the  human  retrovirus  HERV-E  contributes 
enhancer activity to the human amylase gene that allows for salivary gland-specific regulation [3]. 
HERV LTRs have also been proposed to regulate expression of the apolipoprotein-C1 gene in liver, 
and the endothelin-B receptor and pleiotrophin genes in placenta [4]. The role of endogenous LTRs as 
promoters  for  other  human  genes  has  been  recently  reviewed  [5].  Here,  we  comment  on  some 
intriguing  new  developments  reported  by  Beyer  et  al.  [1]  on  the  role  of  ERV-9  LTRs  in  gene 
expression in human male germ cells.  
1. ERV-9 LTR Driven Human Transcripts  
ERV-9 LTRs are found only in the primate genome where they have been maintained for at least 15 
million years [6]. One feature that distinguishes ERV-9 LTRs from other endogenous human LTRs is 
the presences of 14 tandem repeat elements that contain recurrent CCAAT, GTGGGGA and GATA 
nucleotide motifs. These DNA motifs bind transcription factors that are expressed preferentially in 
hematopoietic progenitor cells [7] and in reproductive tissues [8-11]. ERV-9 LTR complexes formed 
by the competitive recruitment of these transcription factors have been reported to modulate human 
globin gene switching, selectively transferring these transcription factors 70 kilobases away to activate 
transcription of the -globin gene in hemapoietic progenitor cells [12].  
Since  ERV-9  transcription  factors  are  highly  evolutionarily  conserved,  ERV-9  LTR  (referred  
to herein as globin ERV-9 LTR) driven GFP gene expression was evaluated in transgenic zebrafish 
and  the  distribution  of  ERV-9  initiated  transcripts  in  zebrafish  was  compared  to  those  found  in  
humans [13]. Using a globin ERV-9 specific sequence probe for in situ hybridization analysis, ERV-9 
initiated gene expression in transgenic zebrafish and in humans occurs in both oocytes and various 
progenitor cells but not testes [13]. The identity of the genes transcribed under the influence of this 
ERV-9 promoter activity in oocytes has not been determined.  
2. TAp63 Isoforms Present in the Human p63 Locus 
From 1979 to the present the tumor suppressor p53 has been extensively studied [14]. Twenty years 
after the initial reports on p53, another member of this gene family, p63, emerged as a gene with 
distinct developmental properties. The p63 gene encodes two transcript isoforms, Np63 and TAp63. 
Np63 and TAp63 have unique promoters and each encode three variants designated  , , and  




TAp63 isoforms is the presence of a unique N-terminal transactivating (TA) domain in the TAp63 
isoform.Np63  is  the  major  functioning  isoform  of  Np63  and  is  abundantly  expressed  in  the 
immature squamous epithelium and basal or reserve cells derived from breast, salivary gland, prostate, 
and cervix [2]. The expression of Np63 is required for the survival and maintenance of progenitor 
cells of stratified squamous epithelia [2]. TAp63 functions as a tumor suppressor inducing apoptosis 
activities similar to those of the p53 protein. Just as p53 monitors and suppresses the initiation of 
tumorigenesis in the genome of somatic cells, TAp63 appears to survey the female germ line for DNA 
damage.  Using  TAp63  isoform-specific  antibodies  it  was  concluded  that  the  TAp63  isoform 
predominantly expressed in oocytes is TAp63. TAp63 was not detected in the testes of newborn or 
adult mice suggesting TAp63 mediated germ line protection is specific to female mice [15]. 
Figure 1. Genomic organization of human p63 locus. The p63 locus contains more than 
one promoter. Arrows designate the transcription initiation sites for the TAp63 (TA) and 
Np63 (N) as well as GTAp63 (GTA) transcripts  from  its  distinct ERV-9 promoter. 
Alternate splicing within the 3' region of the gene results in the formation of the ,  and  
isoforms of the TAp63 and Np63. The main structural domains include the N-terminal 
transactivation domain (TA), specific to the TAp63 and GTApTAp63 isoforms, DNA 
binding (green), oligomerization (yellow), SAM, or sterile alpha motif, a protein-protein 
interaction domain (purple) and the TID transactivation inhibitory domain (orange) [16]. 
The promoter located within the U3 of an ERV-9 LTR initiates transcription of GTAp63. 
The coding region corresponding to the 19 residues in the GTAp63 protein derived from 
the ERV-9 U5 is shown in pink.  
 
3. GTAp63 is Expressed in Male Germ Cells 
The  report  recently  published  by  Beyer  et  al.  describes  a  unique  role  of  an  ERV-9  LTR  in 
regulating expression from the p63 gene  [1]. These investigators discovered that the ERV-9 LTR 




unique transcript encoding germ cell-associated transcriptionally active p63 (GTAp63). GTAp63, in 
contrast  to  TAp63,  is  expressed  at  high  levels  in  spermatogenic  precursors,  but  its  expression  is 
extinguished in mature sperm. GTAp63 is expressed in the diploid spermatogonia of healthy human 
testis, but not in testicular cancer cells. Caspase cleavage of the GTAp63 protein in response to DNA 
damage removes the transcription-inhibitory SAM and TID domains of p63, thereby generating p63 
proteins  with  greater  transcriptional  activity  resulting  in  an  enhanced  proapoptotic  response.  This 
suggests a role for GTAp63 in protecting the genomic integrity of the human male germ line. What is 
unusual about this employment of ERV-9 as an ancillary p63 gene promoter is that a portion of ERV-9 
is incorporated in the GTAp63 protein. ERV-9 like all retroviral LTRs contains U3, R and U5 regions. 
The R region and U5 regions are typically 5' untranslated regions in viral transcripts as well as in 
human genes initiated by ERV LTRs. ERV-9 initiated GTAp63 transcripts, in contrast, yield a protein 
that contains a 19 residue N-terminal segment derived from the U5 region of the ERV-9 LTR itself. 
GTAp63  is  therefore  a  novel  previously  unobserved  class  of  mammalian  protein  representing  an 
expressed virus-host chimera.  
The discovery by Beyer et al. that an ERV-9 LTR initiates transcription of GTAp63 proteins that 
protect the integrity of the male germ line [1], represents a convergence of the two independent lines of 
scientific investigation; the transcription of human genes by ERV-9 LTRs and the function of p63 gene 
products in germ cells. Distinct ERV-9 LTRs control the spatial and temporal regulation of transcripts 
in male germ cells [1] and oocytes [13] and GTAp63 and TAp63 function to maintain the fidelity of 
the male and female germ line, respectively [1,2,15]. Clearly it will be important to resolve the basis 
for the observed differences in p63- and globin-ERV-9 initiated transcription, in human testes and 
oocytes. Antibodies and probes specific for the GTAp63a that distinguish its expression from TAp63a 
will be of great value in delineating the distinctive role of these two proteins in the human line. 
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